Skip to main content

Recursion Pharmaceuticals Inc - Class A

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Recursion Pharmaceuticals Inc - Class A

Current Price

$2.93

-3.62%

GoodMoat Value

$0.63

78.5% overvalued
Profile
Valuation (TTM)
Market Cap$1.55B
P/E-2.76
EV
P/B1.37
Shares Out527.40M
P/Sales23.27
Revenue$66.41M
EV/EBITDA

Recursion Pharmaceuticals Inc - Class A (RXRX) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$1.55B

P/E Ratio

-2.76

Forward P/E

EPS

$-1.44

PEG Ratio

0.05

Book Value

$2.14

Dividend Yield

Profit Margin

-842.93%

ROE

-49.50%

Dividend History

Dividend Safety

RXRX Dividend Analysis

Recursion Pharmaceuticals Inc - Class A (RXRX) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -2.76. Profit margin: -842.93%. Free cash flow: $-378.28M. This page shows Recursion Pharmaceuticals Inc - Class A's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Recursion Pharmaceuticals Inc - Class A's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.